Janet Hopkins

Hoofd Techniek/Wetenschap/O&O bij AURA BIOSCIENCES, INC.

Vermogen: 1 M $ op 30-04-2024

59 jaar

Health Technology

Consumer Services

Actieve functies van Janet Hopkins

Bedrijven	Functie	Begin	Einde
GYROSCOPE THERAPEUTICS HOLDINGS PLC	Directeur/Bestuurslid	17-02-2022	-
AURA BIOSCIENCES, INC.	Hoofd Techniek/Wetenschap/O&O	16-10-2023	-

Bedrijven	Functie	Begin	Einde
NOVARTIS AG	Corporate Officer/Principal	01-11-2021	01-10-2023
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Algemeen Directeur	01-12-2021	01-10-2023

McMaster University

Doctorate Degree

Internationaal

Operationeel

Director/Board Member	1
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	5
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
AURA BIOSCIENCES, INC.	Health Technology
NOVARTIS AG	Health Technology

Bedrijven in privébezit	2
Gyroscope Therapeutics Holdings Plc Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology